Stay updated on Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.

Latest updates to the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added to the page history. The prior Notice about government funding and the Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA new notice about government funding status and NIH Clinical Center operations appears on the page. The page now shows Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedUI enhancements were added to the history view, including a Show glossary option and color-coded highlights for additions (green) and deletions (red). The revision label was updated to v3.4.0 and includes the No FEAR Act Data note.SummaryDifference0.6%

- Check42 days agoChange DetectedA new site revision label 'Revision: v3.3.4' was added, replacing the previous 'Revision: v3.3.3'. This update is related to internal versioning and does not modify study data or user-facing content.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now shows Revision: v3.3.3 and no longer lists HHS Vulnerability Disclosure or Revision: v3.3.2.SummaryDifference0.1%

- Check92 days agoChange DetectedRecord History now shows a new site revision entry: v3.3.2, updating from v3.2.0. This is a routine platform update; no changes to study details are apparent.SummaryDifference0.1%

Stay in the know with updates to Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.